Copyright: ©Author(s) 2026.
World J Transplant. Jun 18, 2026; 16(2): 119075
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.119075
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.119075
Table 1 Comparison of demographic and clinical characteristics between responders and non-responders, n (%)
| Variable | Non-responders (n = 45) | Responders (n = 63) | P value |
| Mean age (years) | 60.8 | 58.9 | 0.59 |
| Mean BMI | 31.5 | 30.6 | 0.51 |
| Mean eGFR (mL/minute/1.73 m2) | 44.1 | 54.7 | 0.01 |
| Male | 23 (51.1) | 30 (47.6) | 1 |
| Caucasian | 11 (24.4) | 14 (22.2) | 0.82 |
| Black | 33 (73.3) | 48 (76.2) | 0.82 |
| Tacrolimus | 41 (91.1) | 62 (98.4) | 0.2 |
| MPA | 44 (97.8) | 57 (90.5) | 0.24 |
| Steroid | 43 (95.6) | 63 (100.0) | 0.17 |
| Basiliximab | 5 (11.1) | 16 (25.4) | 0.09 |
| Thymoglobulin | 34 (75.6) | 43 (68.3) | 0.4 |
| Diabetes mellitus | 12 (26.7) | 24 (38.1) | 0.3 |
| Hypertension | 16 (35.6) | 23 (36.5) | 1 |
| Moderna vaccine | 23 (51.1) | 36 (57.1) | 0.7 |
| Pfizer vaccine | 21 (46.7) | 26 (41.3) | 0.56 |
| Kidney only transplant | 42 (93.3) | 56 (88.9) | 0.52 |
| Days from transplant to 1st vaccine | 2200.3 | 2156.6 | 0.73 |
- Citation: Basuli D, Ross B, Rebellato LM. Clinical predictors of SARS-CoV-2 vaccine immunogenicity in kidney transplant recipients at a rural center. World J Transplant 2026; 16(2): 119075
- URL: https://www.wjgnet.com/2220-3230/full/v16/i2/119075.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i2.119075